Why the study?
Reports show obesity is linked to better prognosis in some lung diseases, known as the obesity paradox, but the mechanisms remain disputed and not fully understood.
Does obesity improve prognosis in patients with lung diseases compared to normal weight individuals?
Does obesity improve prognosis in patients with lung diseases compared to normal weight individuals?
This review highlights the potential mechanisms underlying the obesity paradox in lung diseases, providing a framework for understanding why obesity might be associated with better prognosis in certain respiratory conditions.
Obesity paradox in pneumonia/ARDS may support survival benefit; hypothesis-generating, should not yet alter weight management.
BACKGROUND: Obesity is a globally increasing health problem that impacts multiple organ systems and a potentially modifiable risk factor for many diseases. Obesity has a significant impact on lung function and is strongly linked to the pathophysiology that contributes to lung diseases. On the other hand, reports have emerged that obesity is associated with a better prognosis than for normal weight individuals in some lung diseases, including pneumonia, acute lung injury/acute respiratory distress syndrome, chronic obstructive pulmonary disease, and lung cancer. The lesser mortality and better prognosis in patients with obesity is known as obesity paradox. While obesity paradox is both recognized and disputed in epidemiological studies, recent research has suggested possible mechanisms. SUMMARY: In this review, we attempted to explain and summarize these factors and mechanisms, including immune response, pulmonary fibrosis, lung function, microbiota, fat and muscle reserves, which are significantly altered by obesity and may contribute to the obesity paradox in lung diseases. We also discuss contrary literature that attributes the "obesity paradox" to confounding. KEY MESSAGES: The review will illustrate the possible role of obesity in the prognosis or course of lung diseases, leading to a better understanding of the obesity paradox and provide hints for further basic and clinical research in lung diseases.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: